Pregnant women who crave the tangy, chilled refreshment of zobo must weigh their desire against a stark reality: medical experts cannot yet vouch for its safety on a regular basis. In a recent interview with PT Health Watch, obstetrician and gynaecologist Emmanuel Arekhandia issued a clear advisory for expectant mothers to tread carefully, pointing to the absence of definitive clinical trials that back the drink's everyday use across all trimesters.
The warning comes even as zobo remains a beloved fixture on Nigerian street corners, at celebration tables, and in homes where it doubles as a natural blood tonic. Its reputation for healthfulness stems from a rich blend of ingredients, yet the scientific rigour needed to pronounce it safe for pregnancy is simply not there.
What is zobo made of?
Zobo is crafted from the dried calyces of the tropical plant Hibiscus sabdariffa. Traditional preparation involves boiling the deep-red petals with ginger, cloves, pineapple, and sugar — a quartet of flavourings that give the drink its signature sweet-sour profile. Nutrition experts say the resulting infusion carries vitamin C, a suite of antioxidants, and trace amounts of iron, which many believe contribute to its blood-enriching properties.
In non-pregnant adults, research has linked hibiscus to modest dips in blood pressure and improvements in certain metabolic markers. But Arekhandia cautions against applying those results to pregnancy, because gestation alters the body's cardiovascular, hormonal, and metabolic systems in profound ways. What is safe for a non-pregnant person cannot be assumed safe for a developing fetus.
What does the evidence say?
Arekhandia acknowledged that a handful of studies have looked at hibiscus as a potential therapy for anaemia and other conditions during pregnancy. However, he described those investigations as too small and methodologically weak to draw any firm conclusion about risks or benefits. "As a result, the available evidence remains insufficient to establish its safety for regular use during pregnancy," he said.
The current body of knowledge, he explained, leans heavily on laboratory and animal work rather than human trials. While these preclinical studies can offer clues, they cannot replicate the complexity of human pregnancy, and the dosage levels used in animal experiments often dwarf what a typical zobo drinker would consume.
Laboratory and animal red flags
Some animal experiments have suggested that concentrated hibiscus extracts can prompt uterine contractions, a finding that raises theoretical concerns about preterm labour. Others have linked very high doses to reduced birth weight and subtle shifts in reproductive hormone levels among offspring. These outcomes have not been validated in humans, and the gap between a lab rat's intake and a moderate serving of zobo remains wide.
Still, obstetricians like Arekhandia view these signals as important enough to warrant caution. When the stakes involve a developing baby, even unconfirmed risks deserve serious consideration, especially when alternative beverages are abundant.
Medication interactions and blood pressure
Beyond reproductive concerns, hibiscus is known to interact with at least three categories of drugs: chloroquine, paracetamol, and antihypertensives. Arekhandia noted that while the clinical significance of these interactions during pregnancy is unclear, the potential for altered drug efficacy exists. Women who rely on medication to manage blood pressure or infections should be particularly careful, as hibiscus may either amplify or weaken the effects of their prescriptions.
The drink's blood-pressure-lowering property also cuts both ways. For some people, this effect is beneficial; for a pregnant woman with normal or low pressure, excessive intake could trigger dizziness, fainting, or dangerous hypotension. The risk intensifies for those already on antihypertensive therapy, because hibiscus might push pressure below safe levels.
Is any amount considered safe?
Arekhandia was explicit: no definitive human evidence links an occasional serving of traditionally brewed zobo to miscarriage, birth defects, or other adverse outcomes. Yet the shield of "no proof" does not constitute proof of safety. He advised pregnant women who decide to drink zobo to limit themselves to small, occasional servings prepared the classic way — no concentrated extracts, powders, or daily infusions.
His guidance: avoid daily consumption, avoid multiple glasses of hibiscus-water per day, and steer clear of homemade concoctions, supplements, or any product that boosts the concentration of hibiscus far beyond a normal drink. Moderation, in his view, is the only defensible middle ground until robust human studies arrive.
What if you have already taken zobo?
For women who have already consumed zobo during pregnancy, the expert offers reassurance. "There is no evidence to suggest that occasional intake is likely to cause harm," he said. Still, he urges them to stop regular consumption immediately and remain faithful to antenatal care appointments. Anyone who experiences vaginal bleeding, persistent abdominal pain, or reduced fetal movement after drinking zobo should seek emergency medical attention without delay.
The overarching message from Arekhandia and fellow experts converges on a single, pragmatic principle: when uncertainty rules, caution is the safest prenatal companion. As the scientific community waits for quality human trials, Nigerian women will have to balance cultural habit with medical prudence.
